Refractory autoimmune hepatitis in children: Considerations for assessment and management

doi:10.4254/wjh.v17.i12.110966

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 12

This Article

(44)

(65)

(0)

(1259)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Dec 27, 2025; 17(12): 110966
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.110966

Full Size Figure Download Figure

Figure 4 Suggested treatment algorithm for children with refractory autoimmune hepatitis. ¹If mycophenolate mofetil used as second line agent. ²In children with concomitant type 1 diabetes mellites. Modified from Mack et al[2] and Mieli-Vergani et al[37].

Citation: Valamparampil J, Brown RM, McKiernan P. Refractory autoimmune hepatitis in children: Considerations for assessment and management. World J Hepatol 2025; 17(12): 110966
URL: https://www.wjgnet.com/1948-5182/full/v17/i12/110966.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i12.110966

Valamparampil J, Brown RM, McKiernan P. Refractory autoimmune hepatitis in children: Considerations for assessment and management. World J Hepatol 2025; 17(12): 110966 [PMID: 41479508 DOI: 10.4254/wjh.v17.i12.110966]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.